The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways
Abstract
MicroRNAs have essential functional roles in brain development and neuronal specification but their roles in neurodegenerative diseases such as Alzheimer's disease (AD) is unknown. Using a sensitive qRT-PCR platform we identified regional and stage-specific deregulation of miRNA expression in AD patient brains. We used experimental validation in addition to literature to reveal how the deregulated brain microRNAs are biomarkers for known and novel pathways in AD pathogenesis related to amyloid processing, neurogenesis, insulin resistance, and innate immunity. We additionally recovered miRNAs from cerebrospinal fluid and discovered AD-specific miRNA changes consistent with their role as potential biomarkers of disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We detected a relatively smaller number of miRNAs in CSF, compared to other miRNA profiling studies19,28.”
From Intra- and Inter-individual Variability of microRNA Levels in Human Cerebrospinal Fluid: Critical Implications for Biomarker Discovery (2017) · cites this paper as [28]
In the citing paper
“Although the level of miR-9-5p was downregulated in AD brains and EVs from CSF [47,48,49]”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“Similar to miR-146a-5p, miR-132-3p was reported to be downregulated in AD in five independent studies [48,72,80,84] but up-regulated in AD in only one independent study [81].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“Among these miRNAs, miR-146a-5p [50,70,73,74,83] and miR-132-3p [48,72,80,81,84] were reported to be dysregulated in six independent AD studies, respectively.”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“miR-125b-5p was upregulated in brains [36,48,50] and EVs from CSF of AD patients compared to HC [49,66].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“Substantial recent evidence has demonstrated that microRNAs (miRNAs) are dysregulated already early on in AD pathology [2–7].”
From microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer’s disease patients (2026) · cites this paper as [4]
In the citing paper
“miR-92a-1-5p expression in AD brain is enhanced, while miR-501-3p expression is increased in both brain and serum of AD patients [41–43].”
From Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability (2025) · cites this paper as [43]
In the citing paper
“miR-92a-1-5p expression in AD brain is enhanced, while miR-501-3p expression is increased in both brain and serum of AD patients [41–43].”
From Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability (2025) · cites this paper as [43]
In the citing paper
“Both miRNAs are expressed in the human brain and are deregulated in AD [41–43, 54].”
From Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability (2025) · cites this paper as [43]
In the citing paper
“Many studies have detected extracellular/circulating miRNAs in biological fluids, such as plasma and serum (117, 118), cerebrospinal fluid (119), saliva (120), breast milk (121), urine, tears, colostrum, peritoneal fluid, bronchial lavage, seminal fluid (122), and ovarian follicular fluid (123).”
From Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation (2018) · cites this paper as [119]
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,989
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S., Großhans, H., Shingara, J., Byrom, M., JARVIS, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,699
MicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,153
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
Flagged first, then by citations
1 of the 65 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 945
Li, L., Chen, H., Chen, F., Li, F., Wang, M., Wang, L., Li, Y.-Q., & Gao, D. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8244-z · Cited by 32
Dias, I. H. K., Brown, C. L., Shabir, K., Polidori, M. C., & Griffiths, H. R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180201 · Cited by 32
miR-124 regulates cerebromicrovascular function in APP/PS1 transgenic mice via C1ql3
Li, A.-D., Tong, L., Xu, N., Yao, Y., Nie, P.-Y., Wang, Z., & Ji, L.-L. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.09.002 · Cited by 34
Klatt, C. L., Theis, V., Hahn, S. A., Theiß, C., & Matschke, V. (2019) · Cells · doi:10.3390/cells8091077 · Cited by 31
Current Technologies for RNA-Directed Liquid Diagnostics
Martinez-Dominguez, M. V., Zottel, A., Šamec, N., Jovčevska, I., Dincer, C., Kahlert, U. D., & Nickel, A. (2021) · Cancers · doi:10.3390/cancers13205060 · Cited by 32
miR ‐146b Protects the Perinatal Brain against Microglia‐Induced Hypomyelination
Bokobza, C., Joshi, P., Schang, A., Csaba, Z., Faivre, V., Montané, A., Galland, A., Benmamar‐Badel, A., Bosher, E., Lebon, S., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26263 · Cited by 39
Graphene Oxide Modified Chemically Activated Graphite Electrodes for Detection of microRNA
Erdem, A., Ekşin, E., Isin, D., & Polat, D. (2017) · Electroanalysis · doi:10.1002/elan.201600761 · Cited by 33
Llorens, F., Thüne, K., Martı́, E., Kanata, Ε., Dafou, D., Lucena, D. D., Vivancos, A. P., Shomroni, O., Zafar, S., Schmitz, M., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006802 · Cited by 32
Roy, J., & Mallick, B. (2017) · Genomics · doi:10.1016/j.ygeno.2017.02.006 · Cited by 35
Reale, M., Gonzales-Portillo, I., & Borlongan, C. V. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146535 · Cited by 33
Fazeli, S., Motovali-Bashi, M., Peymani, M., Hashemi, M., Etemadifar, M., Nasr‐Esfahani, M. H., & Ghaedi, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240855 · Cited by 30
Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease
Kaundal, R. K., Datusalia, A. K., & Sharma, S. S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106018 · Cited by 32
Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions
Xu, Y., Zhang, X., Pu, S., Wu, J., Lv, Y., & Du, D. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu090 · Cited by 31
Zhou, H., Zhang, R., Lu, K., Yu, W., Xie, B., Cui, D., Jiang, L., Zhang, Q., & Xu, S. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.038 · Cited by 31
Cosín‐Tomás, M., Álvarez‐López, M. J., Companys‐Alemany, J., Kaliman, P., González-Castillo, C., Ortuño‐Sahagún, D., Pallàs, M., & Griñán‐Ferré, C. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00596 · Cited by 31
Hypoxia-Induced MicroRNA-210 Targets Neurodegenerative Pathways
Watts, M. E., Williams, S., Nithianantharajah, J., & Claudianos, C. (2018) · Non-Coding RNA · doi:10.3390/ncrna4020010 · Cited by 30
Zolochevska, O., & Taglialatela, G. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01868-8 · Cited by 30
Hu, F., Hu, P., Chen, Y., Sun, H., Cai, J., He, X., Cao, Q., Yin, M., Zhang, Y., Li, Q., et al. (2023) · Theranostics · doi:10.7150/thno.81826 · Cited by 31
Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease
Zhao, Y., Alexandrov, P. N., & Lukiw, W. J. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00059 · Cited by 30
McDonald, M. K., & Ajit, S. K. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.11.015 · Cited by 32
MicroRNA-1247 inhibits cell proliferation by directly targeting ZNF346 in childhood neuroblastoma
Wu, T., Lin, Y., & Xie, Z. (2018) · Biological Research · doi:10.1186/s40659-018-0162-y · Cited by 29
Pierouli, K., Papakonstantinou, E., Papageorgiou, L., Diakou, I., Mitsis, Τ., Dragoumani, K., Spandidos, D. A., Bacopoulou, F., Chrousos, G. P., Goulielmos, G. N., et al. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5208 · Cited by 29
Chu, Y., Ko, C., Wang, W., Wang, S., Gean, P., Kuo, Y., & Wang, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9359-z · Cited by 29
Impedimetric genosensor for miRNA-34a detection in cell lysates using polypyrrole
Mandli, J., & Amine, A. (2017) · Journal of Solid State Electrochemistry · doi:10.1007/s10008-017-3819-5 · Cited by 29
Plasma miRNAs across the Alzheimer's disease continuum: Relationship to central biomarkers
Liu, S., Park, T., Krüger, D. M., Centeno, T. P., Burkhardt, S., Schütz, A., Huang, Y.-N., Rosewood, T. J., Chaudhuri, S., Cho, M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14230 · Cited by 32
Sibley, C. R., & Wood, M. J. A. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0781-z · Cited by 28
Inflammatory Cytokine, IL-1β, Regulates Glial Glutamate Transporter via microRNA-181a in vitro
Zumkehr, J., Rodríguez‐Ortiz, C. J., Medeiros, R., & Kitazawa, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170828 · Cited by 28
Kesici, E., Ekşin, E., & Erdem, A. (2018) · Sensors · doi:10.3390/s18092868 · Cited by 28
Bazrgar, M., Khodabakhsh, P., Mohagheghi, F., Prudencio, M., & Ahmadiani, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104729 · Cited by 29
A Comprehensive Analysis of MicroRNAs in Human Osteoporosis
Huai, Y., Zhang, W., Chen, Z., Zhao, F., Wang, W. T., Dang, K., Xue, K., Gao, Y., Jiang, S., Miao, Z., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.516213 · Cited by 32
Peplow, P., & Martinez, B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.330591 · Cited by 31
Manzano-Crespo, M., Atienza, M., & Cantero, J. L. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0174-8 · Cited by 28
Copy Number Variants in miR-138 as a Potential Risk Factor for Early-Onset Alzheimer’s Disease
Boscher, E., Husson, T., Quenez, O., Laquerrière, A., Marguet, F., Cassinari, K., Wallon, D., Martinaud, O., Charbonnier, C., Nicolas, G., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180940 · Cited by 27
Wallach, T., Wetzel, M., Dembny, P., Staszewski, O., Krüger, C., Buonfiglioli, A., Prinz, M., & Lehnardt, S. (2020) · Cells · doi:10.3390/cells9010186 · Cited by 26
Microarray microRNA profiling of urinary exosomes in a 5XFAD mouse model of Alzheimer’s disease
Song, Z., Qu, Y., Xu, Y., Zhang, L., Zhou, L., Han, Y., Zhao, W., Yü, P., Zhang, Y., Li, X., et al. (2021) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12175 · Cited by 27
Electrochemical miRNA-34a-based biosensor for the diagnosis of Alzheimer’s disease
Pereira, R. L., Oliveira, D., Pêgo, A. P., Santos, S. D., & Moreira, F. T. C. (2023) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2023.108553 · Cited by 27
Paving the path to HIV neurotherapy: Predicting SIV CNS disease
Beck, S. E., Queen, S. E., Witwer, K. W., Pate, K. A. M., Mangus, L. M., Gama, L., Adams, R. J., Clements, J. E., Zink, M. C., & Mankowski, J. L. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.018 · Cited by 27
Genomics in Neurological Disorders
Han, G., Sun, J., Wang, J., Bai, Z., Song, F., & Lei, H. (2014) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2014.07.002 · Cited by 29
Sun, L., Yan, M., Hu, X., Peng, L.-W., Che, H., Bao, Y., Guo, F., Liu, T., Chen, X., Zhang, R., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0032-9 · Cited by 27
Furr, J. W., Morales‐Scheihing, D., Manwani, B., Lee, J., & McCullough, L. D. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08568-0 · Cited by 29
Unveiling new disease, pathway, and gene associations via multi-scale neural network
Gaudelet, T., Malod-Dognin, N., Sánchez-Valle, J., Pancaldi, V., Valencia, A., & Pržulj, N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231059 · Cited by 25
Yoon, H., Belmonte, K. C., Kasten, T., Bateman, R., & Kim, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-13031-w · Cited by 26
The miR-146a-5p and miR-125b-5p levels as biomarkers for early prediction of Alzheimer's disease
Yashooa, R. K., & Nabi, A. Q. (2022) · Human Gene · doi:10.1016/j.humgen.2022.201129 · Cited by 27
Lu, Y., Peng, R., Dong, L., Xia, K., Wu, R., Xu, S., & Wang, J. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad378 · Cited by 31
The Utility of Gene Expression in Blood Cells for Diagnosing Neuropsychiatric Disorders
Woelk, C. H., Singhania, A., Pérez‐Santiago, J., Glatt, S. J., & Tsuang, M. T. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00003-1 · Cited by 26
Garza-Manero, S., Pichardo‐Casas, I., Arias, C., Vaca, L. A., & Zepeda, A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.12.009 · Cited by 28
Circulating microRNAs in Neurodegenerative Diseases
Grasso, M., Piscopo, P., Crestini, A., Confaloni, A., & Denti, M. A. (2015) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-0955-9_7 · Cited by 26
Into the Fourth Dimension: Dysregulation of Genome Architecture in Aging and Alzheimer’s Disease
Winick‐Ng, W., & Rylett, R. J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00060 · Cited by 28
Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic Mice
Hoyk, Z., Tóth, M. E., Lénárt, N., Nagy, D., Dukay, B., Csefová, A., Zvara, Á., Seprényi, G., Kincses, A., Walter, F. R., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00380 · Cited by 28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Poloni, T. E., Medici, V., Carlos, A. F., Davin, A., Ceretti, A., Mangieri, M., Cassini, P., Vaccaro, R., Zaccaria, D., Abbondanza, S., et al. (2020) · Journal of Visualized Experiments · doi:10.3791/60296 · Cited by 28
MiR-186-5p Dysregulation Leads to Depression-like Behavior by De-repressing SERPINF1 in Hippocampus
Jiang, M., Gu, Y., Cai, J.-F., Wang, A., He, Y., & Feng, Y. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.10.005 · Cited by 26
Shivji, G. G., Dhar, R., & Devi, A. (2022) · Biomarkers · doi:10.1080/1354750x.2022.2067233 · Cited by 26
Umoh, I. O., Reis, H. J., & de Oliveira, A. C. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25053044 · Cited by 28
Prediction of miRNA-mRNA associations in Alzheimer’s disease mice using network topology
Noh, H., Park, C., Park, S., Lee, Y. S., Cho, S. Y., & Seo, H. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-644 · Cited by 27
Anitha, A., & Thanseem, I. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_5 · Cited by 25
Let’s make microglia great again in neurodegenerative disorders
Guillot‐Sestier, M., & Town, T. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1792-x · Cited by 26
Neuroepigenetics and Alzheimer’s Disease: An Update
Zusso, M., Barbierato, M., Facci, L., Skaper, S. D., & Giusti, P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180259 · Cited by 28
Possible epigenetic regulatory effect of dysregulated circular RNAs in Alzheimer’s disease model
Lee, W. J., Moon, J., Jeon, D., Shin, Y., Yoo, J.-S., Park, D.-K., Lee, S., Jung, K., Park, K., Jung, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48471-z · Cited by 26
Alzheimer’s Disease: the Potential of Epigenetic Treatments and Current Clinical Candidates
Coneys, R., & Wood, I. C. (2020) · Neurodegenerative Disease Management · doi:10.2217/nmt-2019-0034 · Cited by 26
Identification of Biomarkers Associated With Alzheimer’s Disease by Bioinformatics Analysis
Zhao, Y., Tan, W., Sheng, W., & Li, X. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515588181 · Cited by 25
Spatiotemporal regulation of GSK3β levels by miRNA-26a controls axon development in cortical neurons
Lucci, C., Mesquita-Ribeiro, R., Rathbone, A., & Dajas‐Bailador, F. (2020) · Development · doi:10.1242/dev.180232 · Cited by 32
Kim, H., Yim, D., Jeon, S., Kang, T. W., Hwang, I., Lee, S., Yang, J., Ju, J., So, Y., & Kim, J. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112401 · Cited by 26
Varma-Doyle, A. V., Lukiw, W. J., Zhao, Y., Lovera, J. F., & Devier, D. J. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117202 · Cited by 26
Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration
MARATOVICH, B. A., Al-Yozbaki, M., George, A., Niyazova, R. Y., Sharipov, K. O., Byrne, L. J., & Wilson, C. M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210817150141 · Cited by 27
Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
Rosa, F. L., Mancuso, R., Agostini, S., Piancone, F., Marventano, I., Saresella, M., Hernis, A., Fenoglio, C., Galimberti, D., Scarpini, E. A., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14111187 · Cited by 26
(2011) · Europe PMC (PubMed Central) · Cited by 25
Exploring the selective vulnerability in Alzheimer disease using tissue specific variant analysis
Dharshini, S. A. P., Taguchi, Y., & Gromiha, M. M. (2018) · Genomics · doi:10.1016/j.ygeno.2018.05.024 · Cited by 25
Exploratory study of sport-related concussion effects on peripheral micro-RNA expression
Svingos, A., Asken, B., Bauer, R., Dekosky, S., Hromas, G. A., Jaffee, M. S., Hayes, R., & Clugston, J. (2019) · Brain Injury · doi:10.1080/02699052.2019.1573379 · Cited by 25
Detection of Serum microRNAs From Department of Defense Serum Repository
Woeller, C. F., Thatcher, T. H., Twisk, D. V., Pollock, S. J., Croasdell, A., Kim, N., Hopke, P. K., Xia, X., Thakar, J., Mallon, T. M., et al. (2016) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000742 · Cited by 24
Differential miRNA expression in the three-spined stickleback, response to environmental changes
Rastorguev, S., Nedoluzhko, A., Gruzdeva, N. M., Boulygina, E., Сергеевич, Ш. Ф., Ibragimova, A. S., Tsygankova, S., Artemov, A. V., Skryabin, K. G., & Prokhortchouk, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-18128-w · Cited by 24
MicroRNA as Therapeutics for Age-Related Macular Degeneration
Natoli, R., & Fernando, N. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-75402-4_5 · Cited by 24
Jiang, C., Logan, S., Yan, Y., Inagaki, Y., Arzua, T., Ma, P., Lu, S., Bosnjak, Z. J., & Bai, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-32474-3 · Cited by 24
The role of microRNA-485 in neurodegenerative diseases
Ryu, I. S., Kim, D. H., Cho, H.-J., & Ryu, J.-H. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0039 · Cited by 25
Bhatnagar, D., Ladhe, S., & Kumar, D. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03446-0 · Cited by 26
Luo, T., Yin, S., Shi, R., Xu, C., Wang, Y., Cai, J., Yue, Y., & Wu, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119336 · Cited by 24
MicroRNA Landscape in Alzheimer’s Disease
Cogoni, C., Ruberti, F., & Barbato, C. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150116123305 · Cited by 24
Hou, X., Gong, X., Zhang, L., Li, T., Yuan, H., Xie, Y., Peng, Y., Qiu, R., Xia, K., Tang, B., et al. (2019) · Epigenomics · doi:10.2217/epi-2019-0081 · Cited by 24
Xin, D., Li, T., Zhao, Y., Guo, X., Gai, C., Jiang, Z., Yu, S., Cheng, J., Song, Y., Cheng, Y., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02782-0 · Cited by 23
Woeller, C. F., Thatcher, T. H., Twisk, D. V., Pollock, S. J., Croasdell, A., Hopke, P. K., Xia, X., Thakar, J., Sime, P. J., Mallon, T. M., et al. (2016) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000769 · Cited by 23
Hu, L., Stasheuski, A. S., Wegman, D. W., Wu, N., Yang, B. B., Hayder, H., Peng, C., Liu, S. K., Yousef, G. M., & Krylov, S. N. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00707 · Cited by 23
Blood Circulating Mirnas As Biomarkers of Alzheimer’S Disease: A Systematic Review and Meta-Analysis
Zhang, Y.-H., Bai, S.-F., & Yan, J. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0341 · Cited by 24
Dakterzada, F., Targa, A., Benitez, I. D., Romero, L., de Gonzalo‐Calvo, D., Torres, G., Moncusí‐Moix, A., Huerto, R. P., Sánchez‐de‐la‐Torre, M., Barbé, F., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00735-x · Cited by 23
Identifying Key MicroRNA Signatures for Neurodegenerative Diseases With Machine Learning Methods
Li, Z., Guo, W., Ding, S., Chen, L., Feng, K., Huang, T., & Cai, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.880997 · Cited by 23
Wen, Q., Verheijen, M. C. T., Wittens, M. M. J., Czuryło, J., Engelborghs, S., Hauser, D. A., van Herwijnen, M. H. M., Lundh, T., Bergdahl, I. A., Kyrtopoulos, S. Α., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20305-5 · Cited by 23
Chandrasekaran, S., & Bonchev, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0144052 · Cited by 24
Neault, M., Couteau, F., Bonneau, É., Guire, V. D., & Mallette, F. A. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.001 · Cited by 23
Defining Larger Roles for “Tiny” RNA Molecules: Role of miRNAs in Neurodegeneration Research
Yelamanchili, S. V., & Fox, H. S. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9172-4 · Cited by 23
MicroRNA Function in Human Diseases
Natarajan, S. K., Smith, M. A., Wehrkamp, C. J., Mohr, A. M., & Mott, J. L. (2013) · Medical Epigenetics · doi:10.1159/000356447 · Cited by 23
Electrochemical detection of microRNAs by graphene oxide modified disposable graphite electrodes
Ekşin, E., & Erdem, A. (2018) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2018.01.015 · Cited by 24
Dakterzada, F., Benitez, I. D., Targa, A., Lladó, A., Torres, G., Romero, L., de Gonzalo‐Calvo, D., Moncusí‐Moix, A., Tort‐Merino, A., Huerto, R. P., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.705989 · Cited by 22
The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors
Geisler, L. J., Mohr, R. U., Lambrecht, J., Knorr, J., Jann, H., Loosen, S. H., Özdirik, B., Luedde, T., Hammerich, L., Tacke, F., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168569 · Cited by 23
MicroRNAs in the pathophysiology of Alzheimer’s disease and Parkinson's disease: an overview
Khezri, M. R., Yousefi, K., Zolbanin, N. M., & Ghasemnejad‐Berenji, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02727-4 · Cited by 22
Epigenomics of Alzheimer's Disease
Cacabelos, R., Torrellas, C., & Lopez-Munoz, F. J. (2014) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2014.03.010 · Cited by 24
Do Neural Cells Communicate with Endothelial Cells via Secretory Exosomes and Microvesicles?
Smalheiser, N. R. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/383086 · Cited by 22
Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and disease
Cathcart, P. J., Lucchesi, W., Ottaviani, S., de Giorgio, A., Krell, J., Stebbing, J., & Castellano, L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.07.003 · Cited by 23
Developmental profiling of microRNAs in the human embryonic inner ear
Chadly, D. M., Best, J., Ran, C., Bruska, M., Woźniak, W., Kempisty, B., Schwartz, M., LaFleur, B., Kerns, B. J., Kessler, J. A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191452 · Cited by 22
Chum, P. P., Hakim, M. A., & Behringer, E. J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215223 · Cited by 21
Insights on the functional interactions between miRNAs and copy number variations in the aging brain
Persengiev, S. P., Kondova, I. I., & Bontrop, R. E. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00032 · Cited by 21
Complex role of microRNAs in HTLV-1 infections
Sampey, G. C., Duyne, R. V., Currer, R., Das, R., Narayanan, A., & Kashanchi, F. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00295 · Cited by 24
Hill, W. J. L. J. M. (2014) · Journal of Aging Science · doi:10.4172/2329-8847.1000119 · Cited by 23
Metadata
- Authors
- Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., Prinjha, R. K., Richardson, J. C., Saunders, A. M., Roses, A. D., & Richards, C. A.
- Affiliations
- GlaxoSmithKline (United States) (US)
- Asuragen (United States) (US)
- Molecular Cell Biology-RandD, Applied Biosystems Foster City, CA, USA
- GlaxoSmithKline (United Kingdom) (GB)
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2008-05-09
- Volume
- 14
- Issue
- 1
- Pages
- 27-41
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W32204808
- Cited by
- 943
- References
- 65
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 28 · 2023: 35 · 2022: 50 · 2021: 78 · 2020: 62 · 2019: 60 · 2018: 69 · 2017: 65 · 2016: 64 · 2015: 83 · 2014: 71 · 2013: 74 · 2012: 50
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GlaxoSmithKline
- National Institute on Aging (NIA AG05128)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, microRNA
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Amyloid, Brain, Cerebellum, Female, Frontal Lobe, Gene Expression Regulation, Genetic Markers, Hippocampus, Humans, Immunity, Innate, Insulin Resistance, Male, Middle Aged, Neurons, RNA, Messenger, Transfection, Biomarkers, Reverse Transcriptase Polymerase Chain Reaction, MicroRNAs, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
